Navigation Links
WUSTL engineer using Jello to study waves in brain from traumatic impact
Date:9/19/2013

The human body has a lot of jobs to do, and its mechanical features, such as strength and flexibility, are important to how well it does them. Washington University in St. Louis engineers are now applying a new imaging technique to a model of brain tissue to see how stiff or soft it might be.

Philip Bayly, PhD, the Lilyan and E. Lisle Hughes Professor of Mechanical Engineering and chair the Department of Mechanical Engineering & Materials Science, has received a three-year, $429,222 grant from the National Science Foundation to study directionally dependent mechanical properties in muscle, white matter in the brain or artificial tissue.

In the brain, white matter holds the nerve fibers that wire cells together. Fibers in tissue also determine mechanical stiffness and strength and influence in which direction waves travel during motion. But these fibers also make it difficult to measure the properties without taking invasive measures.

Bayly and Joel Garbow, PhD, research associate professor of radiology at the School of Medicine, plan to use magnetic resonance elastrography (MRE), a non-invasive technique, to view and measure different properties of waves when they travel in different directions in the fibrous materials. There are a variety of factors that come into play.

"The speed of the waves depends on the stiffness of the material," he says. "The more stiff the material, the faster the waves travel. In fibrous materials, such as muscle and white matter in the brain, stiffness depends on direction. So we plan to use waves propagating in different directions with different polarizations to study the mechanical properties of these tissues."

What they determine could ultimately lead to new diagnostic tools for nerve and brain disorders and new insight into how artificial tissue degrades over time.

This research is related to Bayly's National Institutes of Health-funded work into understanding brain biomechan
'/>"/>

Contact: Neil Schoenherr
nschoenherr@wustl.edu
314-935-5235
Washington University in St. Louis
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. New report reviews science and engineering quality at national security laboratories
2. Scientists engineer strain of MERS coronavirus for use in a vaccine
3. MARC travel awards announced for the 2013 Biomedical Engineering Society annual meeting
4. Bioinspired and Nanoengineered Surfaces: Technologies, Applications and Global Markets
5. UT Arlington engineer to design prototype that predicts flash flooding
6. Tufts Engineer Qiaobing Xu named 2013 Pew Scholar
7. Genetic engineering alters mosquitoes sense of smell
8. Engineered stem cell advance points toward treatment for ALS
9. Frontiers launches new open-access journal in Bioengineering and Biotechnology
10. Fast new, 1-step genetic engineering technology
11. Engineered microbes grow in the dark
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... ALBANY, New York , August 5, 2015 /PRNewswire/ ... new market report titled "Facial Recognition Market - Global ... - 2022", the global market for facial recognition is ... market is driven by increased demand for surveillance systems ... to the rising number of crimes and terrorist activities ...
(Date:8/3/2015)... Aug. 3, 2015 Synaptics, Inc. (Nasdaq: ... today announced that members of the executive management team ... Crest Global Technology Leadership Forum on Tuesday, August 11, ... be held at the Sonnenalp Resort in ... may include forward-looking information. An audio webcast of the ...
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... A new analysis has provided a comprehensive comparison of ... breast cancer are at high risk of recurrence beyond ... endocrine treatment. The promising new findings will likely ... whose cancer recurs more than five years after diagnosis, ...
... led by prominent breast cancer experts from Europe and ... prospects for targeted therapies, and brings opportunities of truly ... said at the 5th IMPAKT Breast Cancer Conference in ... ,translational, breast cancer research that is beginning to have ...
... healthy people have been bombarded by stories in the media ... vitamin D levels, and urging high doses of supplements to ... to diabetes. But new research from Johns Hopkins finds ... the top of the range suggested by the Institute of ...
Cached Biology News:Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer 2Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer 3Study opens new prospects for developing new targeted therapies for breast cancer 2Study opens new prospects for developing new targeted therapies for breast cancer 3Vitamin D: More may not be better 2
(Date:9/2/2015)... , September 2, 2015 ... des Wettbewerbs BeHEARD von 2015 bekanntgeben zu können. ... Rare Genomics Institute. Biovista unterstützt mit ... für die Behandlung anderer Krankheiten als denen, für ... Laffoon und sein Team bei der Wylder ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry Recycling's ... entire waste to energy process and continue to contribute to the sustainability of ... Temarry’s Waste to Energy process has been operating at their Mexico facility, Recicladora ...
(Date:9/1/2015)... September 2, 2015 ... die Forschung und Entwicklung neuartiger Therapien für ... Darmerkrankungen und Reizdarm konzentriert, erhält vom US ... sein neues Medikament patentiert wird. Das Medikament ... bei Kindern verhindert und Entzündungen vorbeugt.   ...
(Date:9/1/2015)... Sept. 1, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... and commercialization of targeted antiviral therapies, announced today that ... th Annual Global Investment Conference sponsored by ... 2015 at The St. Regis Hotel in ... James Sapirstein , Chief Executive Officer, will provide an ...
Breaking Biology Technology:Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2Temarry Recycling’s New $100,000 Waste to Energy Renovation 2Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... Inverness Medical,Innovations, Inc. (Amex: IMA ), ... for the consumer and professional markets, announced,today that ... 2008 Small and Mid,(Smid) Cap Conference being held ... Boston. Ron Zwanziger, Chief Executive Officer, and Jon ...
... 18 Caliper Life,Sciences, Inc. (Nasdaq: CALP ... Brothers Global Healthcare Conference in Miami, will be ... Kevin Hrusovsky, President and CEO of,Caliper, will be ... live,webcast can be accessed at, http://cc.talkpoint.com/LEHM002/031808a_jw/default.asp?entity=Caliper . An,archived ...
... of Preventing Bacterial Colonization with a ... VANCOUVER, March 18 /PRNewswire-FirstCall/ - Angiotech ... a global specialty pharmaceutical and,medical device company, ... its 960,patient clinical trial comparing its 5-Fluorouracil-coated ...
Cached Biology Technology:Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008 2960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter 2960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter 3960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter 4960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter 5960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter 6960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter 7
OmniSlide Heated Wash Module. 2 independent chambers with precise temperature control from ambient of 5C to 70C. Each chamber holds 1 slide rack (20 slides). Includes 2 x Wash Sleeves, 1 x Slide R...
For cleavage of 6xHis tags from proteins containing a Factor Xa Protease recognition site Efficient 6xHis tag cleavage (greater than 90%), ...
Request Info...
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
Biology Products: